Search

Your search keyword '"Skali, Hicham"' showing total 67 results

Search Constraints

Start Over You searched for: Author "Skali, Hicham" Remove constraint Author: "Skali, Hicham" Publisher elsevier b.v. Remove constraint Publisher: elsevier b.v.
67 results on '"Skali, Hicham"'

Search Results

2. Impact of coronary artery calcium testing on patient management.

3. Prognostic use of echocardiography 1 year after a myocardial infarction

4. Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study

5. Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure.

6. Role of Exercise Treadmill Testing in the Assessment of Coronary Microvascular Disease.

7. Are we asking too much of our trials?

8. Use of Optimal Medical Therapy in Patients With Cardiovascular Disease Undergoing Cardiac Rehabilitation.

9. Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across the Left Ventricular Ejection Fraction Spectrum.

12. Anatomical distribution of traumatic pneumothoraces on chest computed tomography: implications for ultrasound screening in the ED.

13. Association of Heart Rate and Outcomes in a Broad Spectrum of Patients With Chronic Heart Failure: Results From the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) Program

14. Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both.

15. Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation.

16. Incremental value of echocardiographic assessment beyond clinical evaluation for prediction of death and development of heart failure after high-risk myocardial infarction.

17. Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction: The VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.

18. High-risk myocardial infarction in the young: The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.

19. Usefulness of Right Ventricular Fractional Area Change to Predict Death, Heart Failure, and Stroke Following Myocardial Infarction (from the VALIANT ECHO Study)

20. Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.

21. Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial.

22. Alcohol consumption and prognosis in patients with left ventricular systolic dysfunction after a myocardial infarction

23. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction

25. Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality.

26. Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis.

27. Changes in Pulmonary Artery Pressure Late in Life: The Atherosclerosis Risk in Communities (ARIC) Study.

28. Right Ventricular Function and Pulmonary Coupling in Patients With Heart Failure and Preserved Ejection Fraction.

32. Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) Study.

33. Association of Left Atrial Structure and Function With Heart Failure in Older Adults.

34. OBESITY AND ADVERSE CARDIAC REMODELING IN HFPEF: THE PARAGON-HF TRIAL.

36. PREDICTORS AND PROGNOSIS OF INCIDENT POOR NUTRITIONAL STATUS IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: INSIGHTS FROM THE PARAGON-HF TRIAL.

40. Prognostic Significance of Troponin Elevation and Right Ventricular Enlargement in Acute Pulmonary Embolism

41. ASSOCIATION OF BASELINE MODEST ALCOHOL CONSUMPTION AND CORONARY MICROVASCULAR DYSFUNCTION IN THE CARDIOVASCULAR INFLAMMATION REDUCTION TRIAL (CIRT-CFR).

43. Comparison of the Use of Downstream Tests After Exercise Treadmill Testing by Cardiologists Versus Noncardiologists.

44. Yield of Downstream Tests After Exercise Treadmill Testing: A Prospective Cohort Study.

45. Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis.

Catalog

Books, media, physical & digital resources